Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Baumann

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Regulatory Toxicology and Pharmacology : RTP|July 30, 2015
Nonclinical safety testing of biopharmaceuticals--Addressing current challenges of these novel and emerging therapiesFrank R Brennan, Andreas Baumann, Guenter Blaich, et al.
Malaria Journal|February 17, 2012
Naturally acquired immune responses to malaria vaccine candidate antigens MSP3 and GLURP in Guahibo and Piaroa indigenous communities of the Venezuelan AmazonAndreas Baumann, Magda M Magris, Marie-Luz Urbaez, et al.
Regulatory Toxicology and Pharmacology : RTP|January 23, 2018
Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturingPeter Ulrich, Guenter Blaich, Andreas Baumann, et al.
Mabs|July 9, 2021
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership MeetingThomas Kissner, Guenter Blaich, Andreas Baumann, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 27, 2023
Weak Dispersion of Exciton Landé Factor with Band Gap Energy in Lead Halide Perovskites: Approximate Compensation of the Electron and Hole DependencesNatalia E Kopteva, Dmitri R Yakovlev, Erik Kirstein, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 21, 2018
Goal-directed perfusion to reduce acute kidney injury: A randomized trialMarco Ranucci, Ian Johnson, Timothy Willcox, et al.
Renal Failure|December 16, 2025
Hemoadsorption therapy in severe rhabdomyolysis: a report from the international, prospective COSMOS (CytOSorb<sup>®</sup> TreatMent of Critically ill PatientS) registryRicard Ferrer, Bartosz Tyczynski, Julian Kreutz, et al.
Toxicologic Pathology|August 5, 2015
PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical DevelopmentInge A Ivens, William Achanzar, Andreas Baumann, et al.
Journal of Intensive Medicine|November 3, 2025
The international, prospective CytOSorb<sup>Ⓡ</sup> treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patientsRicard Ferrer, Matthias Thielmann, Andreas Kribben, et al.
Cell Reports|January 31, 2023
A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanylGianna Triller, Evi P Vlachou, Hamidreza Hashemi, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Regulatory Toxicology and Pharmacology : RTP|July 30, 2015
Nonclinical safety testing of biopharmaceuticals--Addressing current challenges of these novel and emerging therapiesFrank R Brennan, Andreas Baumann, Guenter Blaich, et al.
Malaria Journal|February 17, 2012
Naturally acquired immune responses to malaria vaccine candidate antigens MSP3 and GLURP in Guahibo and Piaroa indigenous communities of the Venezuelan AmazonAndreas Baumann, Magda M Magris, Marie-Luz Urbaez, et al.
Regulatory Toxicology and Pharmacology : RTP|January 23, 2018
Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturingPeter Ulrich, Guenter Blaich, Andreas Baumann, et al.
Mabs|July 9, 2021
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership MeetingThomas Kissner, Guenter Blaich, Andreas Baumann, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 27, 2023
Weak Dispersion of Exciton Landé Factor with Band Gap Energy in Lead Halide Perovskites: Approximate Compensation of the Electron and Hole DependencesNatalia E Kopteva, Dmitri R Yakovlev, Erik Kirstein, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 21, 2018
Goal-directed perfusion to reduce acute kidney injury: A randomized trialMarco Ranucci, Ian Johnson, Timothy Willcox, et al.
Renal Failure|December 16, 2025
Hemoadsorption therapy in severe rhabdomyolysis: a report from the international, prospective COSMOS (CytOSorb<sup>®</sup> TreatMent of Critically ill PatientS) registryRicard Ferrer, Bartosz Tyczynski, Julian Kreutz, et al.
Toxicologic Pathology|August 5, 2015
PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical DevelopmentInge A Ivens, William Achanzar, Andreas Baumann, et al.
Journal of Intensive Medicine|November 3, 2025
The international, prospective CytOSorb<sup>Ⓡ</sup> treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patientsRicard Ferrer, Matthias Thielmann, Andreas Kribben, et al.
Cell Reports|January 31, 2023
A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanylGianna Triller, Evi P Vlachou, Hamidreza Hashemi, et al.
Pageof 7